Correlations between serum hepatitis B core-related antigen and hepatitis B surface antigen in patients with hepatitis B cirrhosis and a hepatitis B virus-DNA-negative status: a retrospective study

被引:1
作者
Xu, Baiguo [1 ,2 ]
Liu, Anjing [3 ]
Liu, Ying [1 ,2 ]
Han, Tao [1 ,2 ]
Guo, Hua [4 ,5 ]
Ding, Xian [4 ,6 ]
Xiang, Huiling [1 ,2 ]
机构
[1] Tianjin Med Univ, Cent Clin Coll 3, Dept Hepatol & Gastroenterol, 83 Jintang Rd, Tianjin 300170, Peoples R China
[2] Tianjin Inst Hepatobiliary Dis, Tianjin, Peoples R China
[3] Tanggu Infect Dis Hosp Tianjin, Ctr Infect Dis, Tianjin, Peoples R China
[4] Inst Hepatobiliary Dis Tianjin, Tianjin, Peoples R China
[5] Third Cent Hosp Tianjin, Tianjin, Peoples R China
[6] Third Cent Hosp Tianjin, Dept Clin Lab, Tianjin, Peoples R China
关键词
Hepatitis B cirrhosis; hepatitis B surface antigen; HBV-DNA-negative; hepatitis B core-related antigen; liver; serological marker; CLOSED CIRCULAR DNA; HEPATOCELLULAR-CARCINOMA; HBSAG;
D O I
10.1177/03000605221130714
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Objective This study aimed to examine the correlations between serum hepatitis B core-related antigen (HBcrAg) and hepatitis B surface antigen (HBsAg) titers in patients with hepatitis B cirrhosis and a hepatitis B virus (HBV)-DNA-negative status. Methods We retrospectively analyzed the data and blood samples of patients who were diagnosed with HBV liver cirrhosis and an HBV-DNA negative status. These patients were hospitalized between October 2018 and October 2019 at one hospital. Results A total of 180 patients were included. The median (interquartile range) HBsAg and HBcrAg concentrations were 2.77 log(10) IU/mL (1.60-3.15) and 3.96 log(10) U/mL (2.70-4.97), respectively. A non-linear significant relationship was found between HBsAg and HBcrAg concentrations. The inflection point was 0.58. The effect size and confidence interval on the left and right sides of the inflection point were 0.10 (-0.23-0.42) and 0.62 (0.46-0.78), respectively. When HBsAg concentrations were >= 0.58 log(10) IU/mL, HBsAg concentrations were positively correlated with HBcrAg concentrations. When HBsAg concentrations increased by 1 log(10) IU/mL, HBcrAg concentrations increased by 0.62 log(10) U/mL (95% confidence interval: 0.46, 0.78). Conclusions There might be a non-linear relationship between HBcrAg and HBsAg concentrations in patients with hepatitis B cirrhosis and an HBV-DNA-negative status.
引用
收藏
页数:16
相关论文
共 34 条
[1]   Hepatitis B surface antigen quantification: Why and how to use it in 2011-A core group report [J].
Chan, Henry Lik-Yuen ;
Thompson, Alex ;
Martinot-Peignoux, Michelle ;
Piratvisuth, Teerha ;
Cornberg, Markus ;
Brunetto, Maurizia Rossana ;
Tillmann, Hans L. ;
Kao, Jia-Horng ;
Jia, Ji-Dong ;
Wedemeyer, Heiner ;
Locarnini, Stephen ;
Janssen, Harry L. A. ;
Marcellin, Patrick .
JOURNAL OF HEPATOLOGY, 2011, 55 (05) :1121-1131
[2]   Infection and Cancer: The Case of Hepatitis B [J].
Chan, Stephen L. ;
Wong, Vincent W. S. ;
Qin, Shukui ;
Chan, Henry L. Y. .
JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (01) :83-90
[3]   Serum HBcrAg is better than HBV RNA and HBsAg in reflecting intrahepatic covalently closed circular DNA [J].
Chen, En-Qiang ;
Wang, Meng-Lan ;
Tao, Ya-Chao ;
Wu, Dong-Bo ;
Liao, Juan ;
He, Min ;
Tang, Hong .
JOURNAL OF VIRAL HEPATITIS, 2019, 26 (05) :586-595
[4]   Serum hepatitis B core-related antigen is a satisfactory surrogate marker of intrahepatic covalently closed circular DNA in chronic hepatitis B [J].
Chen, En-Qiang ;
Feng, Shu ;
Wang, Meng-Lan ;
Liang, Ling-Bo ;
Zhou, Ling-Yun ;
Du, Ling-Yao ;
Yan, Li-Bo ;
Tao, Chuan-Min ;
Tang, Hong .
SCIENTIFIC REPORTS, 2017, 7
[5]  
Chinese Society of Hepatology Chinese Medical Association, 2015, Zhonghua Gan Zang Bing Za Zhi, V23, P888, DOI 10.3760/cma.j.issn.1007-3418.2015.12.002
[6]   Predictive role of serum HBsAg and HBcrAg kinetics in patients with HBeAg-negative chronic hepatitis B receiving pegylated interferon based therapy [J].
Chuaypen, N. ;
Posuwan, N. ;
Chittmittraprap, S. ;
Hirankarn, N. ;
Treeprasertsuk, S. ;
Tanaka, Y. ;
Shinkai, N. ;
Poovorawan, Y. ;
Tangkijvanich, P. .
CLINICAL MICROBIOLOGY AND INFECTION, 2018, 24 (03) :306.e7-306.e13
[7]   No cure for hepatitis B and D without targeting integrated viral DNA? [J].
Cornberg, Markus ;
Manns, Michael P. .
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2018, 15 (04) :195-196
[8]   The role of quantitative hepatitis B surface antigen revisited [J].
Cornberg, Markus ;
Wong, Vincent Wai-Sun ;
Locarnini, Stephen ;
Brunetto, Maurizia ;
Janssen, Harry L. A. ;
Chan, Henry Lik-Yuen .
JOURNAL OF HEPATOLOGY, 2017, 66 (02) :398-411
[9]   EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection [J].
Lampertico P. ;
Agarwal K. ;
Berg T. ;
Buti M. ;
Janssen H.L.A. ;
Papatheodoridis G. ;
Zoulim F. ;
Tacke F. .
JOURNAL OF HEPATOLOGY, 2017, 67 (02) :370-398
[10]   Phenylpropanolamine and the risk of hemorrhagic stroke. [J].
Kernan, WN ;
Viscoli, CM ;
Brass, LM ;
Broderick, JP ;
Brott, T ;
Feldmann, E ;
Morgenstern, LB ;
Wilterdink, JL ;
Horwitz, RI .
NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (25) :1826-1832